Navigation Links
Sequoia Pharmaceuticals Announces Appointment of Steven D. Skolsky as Chief Executive Officer
Date:10/29/2007

GAITHERSBURG, Md., Oct. 29 /PRNewswire/ -- Sequoia Pharmaceuticals, Inc., which discovers and develops novel antiviral therapeutics as well as pharmacokinetic enhancers, announced today the appointment of Steven D. Skolsky as its President and Chief Executive Officer. He will also serve as a member of the Board of Directors.

"Sequoia is pleased to have recruited such an outstanding, talented leader as Steven Skolsky," said Chris Mirabelli, Chairman of the Board of Sequoia Pharmaceuticals. "Steve has an impressive record of success within the pharmaceutical industry. The combination of his leadership and management experience, as well as his business acumen, makes Steve uniquely qualified to lead us through the exciting times ahead."

"Sequoia possesses an extraordinary scientific pedigree, and a very attractive research portfolio. I am honored to have the opportunity to lead Sequoia, and to build on its outstanding technological progress as we move towards commercialization", said Mr. Skolsky.

Mr. Skolsky brings over twenty-five years of U.S. and international experience in the pharmaceutical and biotechnology arena. He most recently served as chief executive officer of Trimeris, a biotechnology company specializing in HIV therapeutics. Previously Mr. Skolsky had a distinguished career at GlaxoSmithKline where he served as GSK's Senior Vice President of Global Commercial Strategy responsible for world-wide clinical development and product strategy. He also served as managing director of GSK's operations in Australia and New Zealand and previously was Vice President of Sales and Marketing of the HIV/Oncology Division at Glaxo Wellcome. He is a graduate of the University of North Carolina at Chapel Hill.

About Sequoia Pharmaceuticals, Inc.

Sequoia Pharmaceuticals discovers and develops revolutionary new treatments, primarily for viral diseases including HIV/AIDS and HCV-induced hepatitis. In addition, Sequoia has an active R&D progr
'/>"/>

SOURCE Sequoia Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...Johns Hopkins Bloomberg School of Public Health an...f-day symposium to mark the 60th Anniversary of th..., "Public Health and Human Rights: The Work Ahead ...d human rights over the last 60 years. , Navanet...issioner for Human Rights will be the keynote spea...
(Date:11/20/2008)...PRNewswire/ -- Precision Therapeutics Inc., a lead... tests, has secured $43 million,in additional fun...on of,ChemoFx(R). ChemoFx is a diagnostic test t...emotherapeutic regimen for cancer patients. New i...e round and was joined by existing,investors Adam...
(Date:11/20/2008)...Newswire/ -- The UNICEF supported clean-water,cam...at water technology,manufacturer, The Watergeeks ...,the campaign in 2009 -- the third year of this aw...F provide clean water to children around the world...based manufacturer will donate a,percentage of th...
(Date:11/20/2008)...PRNewswire/ -- Precyse Solutions, the leader in,d...rformance through,technology and management solut...uncil of Pennsylvania as "Technology Company of th... the Kimmel Center. The Annual Gala honors the,r... and entrepreneurs. More,than 1200 business lead...
Breaking Medicine News(10 mins):Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 3Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 2Health News:TAP Project Partners With Watergeeks for 2009 Clean Water Campaign 3Health News:Precyse Solutions Honored as 'Technology Company of the Year' 2
...ulletin (DTB) is a highly respected and influentia...ugs they prescribe //. But the sad news is that it...g its funding after 40 years. This journal is sent...ily marketed pills. With respect to this the senio...
...gus implicated in recent eye infections among soft...asing number of cases of keratitis// (corneal swel...ished online today in Archives of Ophthalmology, o...ections caused by fungi can be devastating to both...
...ns during the monsoon season in Kerala, numerous t...s.// It is believed that the months of June and Ju...atment. "In the last five years the number of tou...elated services in Kerala has more than doubled. C...
...onducted by a team of researchers at the Departmen...ebrew University //in Jerusalem it was found that ...terol levels in our body. The report was published...s experimented on lab animals (rats) by feeding th...
Other Medicine News:Health News:Reports Characterize Fungal Eye Infections Among Soft Contact Lens Wearers 2Health News:Reports Characterize Fungal Eye Infections Among Soft Contact Lens Wearers 3Health News:Ayurveda Boosts Monsoon Tourism in Kerala 2
(Date:11/19/2008)...ment from Roche- , , MONTVALE, N.J., Nov. 1... Corp. (Nasdaq: MEMY ) today announced that it h...ial of R3487/MEM 3454, its lead alpha-7 nicotinic ...ed with schizophrenia (CIAS). The Company has ran...ing a $5.0 million payment from its partner Roche....
(Date:11/18/2008)...n,s 2008 Faces of Influenza survey underscores tha...nfluenza; Mother and Gold Medalist Kristi Yamaguch... While 78 percent of mothers in th...tentially life-threatening disease that can strike... will get vaccinated this season, according to a n...
(Date:11/12/2008)...RNewswire-USNewswire/ -- A new study being,publish...lp answer the,question, what causes Parkinson,s di... medical research into,Parkinson,s disease is what... the first place. Answering this question has been... identical types of brain cells that produce,dopam...
(Date:11/12/2008)...rial of its kind shows no clinically meaningful, d...sion of nearsightedness, JACKSONVILLE, Fla., Nov....t result in clinically significant acceleration in...d does not cause relevant increases in axial,lengt...s from the,three-year study, the largest randomize...
Breaking Medicine Technology:Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6A Window Into Parkinson's Disease 2Soft Contact Lenses Do Not Lead to 'Myopic Creep' in Children, Study Shows 2Soft Contact Lenses Do Not Lead to 'Myopic Creep' in Children, Study Shows 3NJIT start up company NeuroTrax named best in show 2796 1NJIT start up company NeuroTrax named best in show 2796 2Attorney Weight Loss Video to be Released by Leventhal Weight Loss Incorporated 16162 1Attorney Weight Loss Video to be Released by Leventhal Weight Loss Incorporated 16162 2Drug Mix Ups Harm Hospitalized Kids 16159 1Drug Mix Ups Harm Hospitalized Kids 16159 2Drug Mix Ups Harm Hospitalized Kids 16159 3War between the sexes begins before twins birth TAU researchers say 2794 1War between the sexes begins before twins birth TAU researchers say 2794 2
...SS WIRE)--Apr 19, 2007 - Abraxis BioScience,Inc. ...ical,company, announced results from two pre-clini...ed protein acidic and rich in,cysteine) expression... (nab(TM)) tumor-targeting technology at the 98th,...nual Meeting held,April 14-18, 2007 in Los Angeles...
...n Immediately Following Transurethral Resection,is...IRVINE, Calif., April 19, 2007 /PRNewswire-FirstCa...nced results of a Phase,2b study of EOquin, in non...reclinical data of SPI (IRL)-1620 and satraplatin,...of Cancer,Research, held at the Los Angeles Conven...
Other Medicine Technology:Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 2Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 3Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 4Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 5Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 2Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 3Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 4Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 5Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 6Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 7Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 8
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: